Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Tipo de estudo
Intervalo de ano
1.
Tunisie Medicale [La]. 2011; 89 (3): 292-294
em Francês | IMEMR | ID: emr-109393

RESUMO

Hydroxyurea [HU] is an antineoplastic drug commonly used to treat chronic myeloproliferative disorders. Dermatological side effects are frequent and usually benign. Leg ulceration following HU therapy is less common. To describe epidemioclinical and therapeutic features of leg ulcers induced by HU. A 70-year-old woman is treated with hydroxyurea for polycythemia vera. One year later; she presented with a malleolar painful ulcer, initially healed without discontinuation of the treatment, but has been recurred 2 months later, becoming multiple and bilateral. HU has been discontinued and ulcers were completely cured. Leg ulcers induced by hydroxyurea are rare. Pathogenesis of HU-induced ulcers remains unknown and is multi factorial. Discontinuation of treatment is still the option of choice for complete recovery


Assuntos
Humanos , Feminino , Úlcera da Perna , Policitemia Vera
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA